DB00095 | Efalizumab | approved, investigational, withdrawn | yes | antibody | Details |
DB02177 | 1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine | experimental | unknown | | Details |
DB03932 | LFA703 | experimental | unknown | | Details |
DB04724 | (S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide | experimental | unknown | | Details |
DB00227 | Lovastatin | approved, investigational | unknown | inhibitor | Details |
DB00098 | Antithymocyte immunoglobulin (rabbit) | approved | yes | | Details |
DB06972 | 7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile | experimental | unknown | | Details |
DB07486 | 3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline | experimental | unknown | | Details |
DB11611 | Lifitegrast | approved | yes | antagonist | Details |
DB00641 | Simvastatin | approved | unknown | inhibitory allosteric modulator | Details |
DB01098 | Rosuvastatin | approved | unknown | inhibitory allosteric modulator | Details |
DB08860 | Pitavastatin | approved | unknown | | Details |